| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |